SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 71.58 |
Enterprise Value ($M) | 45.44 |
Book Value ($M) | 7.43 |
Book Value / Share | 0.06 |
Price / Book | 9.63 |
NCAV ($M) | 6.71 |
NCAV / Share | 0.06 |
Price / NCAV | 10.67 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -4.53 |
Return on Assets (ROA) | -0.70 |
Return on Equity (ROE) | -1.69 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.28 |
Current Ratio | 1.28 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 30.95 |
Assets | 31.67 |
Liabilities | 24.24 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -32.12 |
Net Income | -36.73 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -28.57 |
Cash from Investing | -0.07 |
Cash from Financing | 45.09 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Ra Capital Management, L.p. | 9.90 | 10.00 | |
13G/A | Great Point Partners Llc | 9.99 | 20.49 | |
13G/A | Walleye Capital LLC | 4.82 | 0.00 | |
13G/A | Nantahala Capital Partners Limited Partnership | 2.76 | -61.85 | |
13G/A | Nantahala Capital Management, LLC | 9.99 | 7.09 | |
13G/A | Vivo Opportunity Fund Holdings, L.P. | 9.99 | 1.67 | |
13G/A | Logos Global Management LP | 4.90 | 46.37 | |
13G/A | Biotechnology Value Fund L P | 9.99 | 201.74 | |
13G | Octagon Capital Advisors LP | 9.10 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
36,246 | 179,855 | 20.15 | |
65,339 | 211,278 | 30.93 | |
151,909 | 461,250 | 32.93 | |
271,111 | 1,035,539 | 26.18 | |
(click for more detail) |
Similar Companies | |
---|---|
TRAW – Traws Pharma, Inc. | TSBX – Turnstone Biologics Corp. |
TTNP – Titan Pharmaceuticals, Inc. | UPC – Universe Pharmaceuticals INC |
UPXI – Upexi, Inc. |
Financial data and stock pages provided by
Fintel.io